First experiences with HeartMate 3 follow-up and adverse events

Abstract Background The novel HeartMate 3 (HM3) left ventricular assist device (LVAD) received its CE mark in October 2015. It is a new compact LVAD featuring fully magnetically levitated pump, artificial pulse, large pump gaps, and a modular driveline. Here, we present outcomes and adverse events o...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of thoracic and cardiovascular surgery 2017-07, Vol.154 (1), p.173-178
Hauptverfasser:	Hanke, Jasmin S., MD, Dogan, Günes, MD, Rojas, Sebastian V., MD, Zoch, Amelie, BSc, Feldmann, Christina, PhD, Deniz, Ezin, MD, Avsar, Murat, MD, Warnecke, Gregor, MD, PhD, Haverich, Axel, MD, PhD, Schmitto, Jan D., MD, PhD
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Cardiothoracic Surgery complications Female Heart Failure - diagnosis Heart Failure - mortality Heart Failure - physiopathology Heart Failure - therapy Heart-Assist Devices - adverse effects HeartMate 3 Humans Left ventricular assist device LVAD Male Middle Aged outcomes Prosthesis Design Recovery of Function Retrospective Studies Risk Factors survival Time Factors Treatment Outcome Ventricular Function, Left
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!